Mark Froimson

Insider Reports History

Entity
Individual
Location
C/O Pacira Biosciences, Inc., 5401 West Kennedy Boulevard, Suite 890, Tampa, FL
Signature
/s/ Kristen Williams, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Froimson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pacira BioSciences, Inc. Director Common Stock 14.5K $168K $11.58 Aug 12, 2024 Direct
Pacira BioSciences, Inc. Director Stock Option (Right to Buy) 12.2K Jun 12, 2024 Direct

Insider Reports Filed by Mark Froimson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCRX Pacira BioSciences, Inc. Aug 12, 2024 1 $16.2K 4 Aug 12, 2024 Director
PCRX Pacira BioSciences, Inc. Jun 12, 2024 2 $0 4 Jun 13, 2024 Director
PCRX Pacira BioSciences, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
PCRX Pacira BioSciences, Inc. Jun 6, 2022 2 $0 4 Jun 8, 2022 Director
PCRX Pacira BioSciences, Inc. May 9, 2022 1 -$59.4K 4 May 11, 2022 Director
PCRX Pacira BioSciences, Inc. Dec 17, 2021 1 $0 4 Dec 20, 2021 Director
PCRX Pacira BioSciences, Inc. Jun 9, 2021 2 $0 4 Jun 11, 2021 Director